Golden
Synosia Therapeutics

Synosia Therapeutics

A company developing therapies for psychological and neurological illnesses

All edits

Edits on 26 Mar 2020
Golden AI"Funding autocalculation"
Golden AI edited on 26 Mar 2020 7:30 pm
Edits made to:
Infobox (+1 properties)

Infobox

Total funding amount (USD)
91,500,000
Edits on 14 Jun 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 14 Jun 2019 7:43 pm
Edits made to:
Article (+23/-23 characters)

Article

On January 1, 2009 Synosia Therapeutics completed their series B funding round with $29 million in funding from Investor Growth CapitalInvestor Growth Capital Limited (lead investor), Aravis Ventures (lead investor), Versant Ventures, Swiss Helvetia Fund, Novo Ventures, Abingworth, and 5AM Ventures.

Edits on 12 Jun 2019
Golden AI
Golden AI edited on 12 Jun 2019 9:53 pm
Edits made to:
Infobox (+1 properties)
Golden AI
Golden AI edited on 12 Jun 2019 9:32 pm
Edits made to:
Infobox (+1 properties)
Golden AI
Golden AI edited on 12 Jun 2019 9:27 pm
Edits made to:
Infobox (+1 properties)
Edits on 2 Apr 2019
Dawson Sewell
Dawson Sewell edited on 2 Apr 2019 8:49 pm
Edits made to:
Article (+12/-12 characters)

Article

On March 6, 2006 Synosia Therapeutics completed their series A funding round with $2.5 million in capital from undisclosed investors.

...

On January 5, 2007 Synosia Therapeutics completed a venture capital round with $32.5 million in funding from Versant Ventures, Novo Holdings, Abingworth, and 5AM Ventures5AM Ventures.

...

On January 1, 2009 Synosia Therapeutics completed their series B funding round with $29 million in funding from Investor Growth Capital Limited (lead investor), Aravis Ventures (lead investor), Versant Ventures, Swiss Helvetia Fund, Novo Ventures, Abingworth, and 5AM Ventures.

Dawson Sewell
Dawson Sewell edited on 2 Apr 2019 8:47 pm
Edits made to:
Infobox (+5 properties)
Article (+1079 characters)
Further reading (+2 rows) (+8 cells) (+417 characters)
Categories (-1 topics)
Related Topics (+1 topics)

Article

Synosia Therapeutics is a biotechnology company developing therapies for psychological and neurological illnesses that is headquartered in Basel, Switzerland and was founded in 2006.

Funding

Series A

On March 6, 2006 Synosia Therapeutics completed their series A funding round with $2.5 million in capital from undisclosed investors.

Venture round

On January 5, 2007 Synosia Therapeutics completed a venture capital round with $32.5 million in funding from Versant Ventures, Novo Holdings, Abingworth, and 5AM Ventures.

Series B

On January 1, 2009 Synosia Therapeutics completed their series B funding round with $29 million in funding from Investor Growth Capital Limited (lead investor), Aravis Ventures (lead investor), Versant Ventures, Swiss Helvetia Fund, Novo Ventures, Abingworth, and 5AM Ventures.

Series C

On October 12, 2010 Synosia Therapeutics completed their series C funding round with $30 million in funding from UCB Pharma (lead investor), Versant Ventures, Swiss Halvetia Fund, Novo Holdings, Investor Growth Capital Limited, Aravis Ventures, and 5AM Ventures.

Further reading

Title
Author
Link
Type

BioTie Therapies Corp. to Acquire CNS Therapeutics Firm Synosia Therapeutics in $121.5M All-Shares Deal

BioSpace

Web

Synosia Therapeutics Raises $30M in Series C Financing

FierceBiotech

Web

Infobox

Categories

Related Topics

Edits on 21 Jan 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 Jan 2019 10:13 pm
Edits made to:
Infobox (+1/-1 properties)

Infobox

Edits on 10 Jan 2019
Golden AI
Golden AI edited on 10 Jan 2019 10:21 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 12 Dec 2018
Golden AI"Import data"
Golden AI edited on 12 Dec 2018 1:10 am
Edits made to:
Infobox (+2 properties)
Edits on 3 Nov 2018
Dawson Sewell
Dawson Sewell edited on 3 Nov 2018 3:27 pm
Edits made to:
Categories (+2/-1 topics)
Edits on 19 Jul 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 Jul 2018 8:53 pm

Infobox

Location
Edits on 29 Jun 2018
Golden AI"Update infobox"
Golden AI edited on 29 Jun 2018 5:50 pm
Edits on 18 Jun 2018
Golden AI"Updating description"
Golden AI edited on 18 Jun 2018 10:52 pm
Edits made to:
Description (+75/-21 characters)
Topic thumbnail

Synosia Therapeutics

Biotechnology company

A company developing therapies for psychological and neurological illnesses

Edits on 29 May 2018
Golden AI"Initial topic creation"
Golden AI created this topic on 29 May 2018 9:31 pm
Edits made to:
Description (+21 characters)
Categories (+1 topics)
Topic thumbnail

 Synosia Therapeutics

Biotechnology company

Categories

No more activity to show.